Brown J D, O'Shaughnessy C T, Kilpatrick G J, Scopes D I, Beswick P, Clitherow J W, Barnes J C
Department of Pharmacology, Glaxo Research & Development Ltd., Stevenage, Hertfordshire, UK.
Eur J Pharmacol. 1996 Sep 12;311(2-3):305-10. doi: 10.1016/0014-2999(96)00428-1.
We have examined the specific binding of the tritiated derivative of the potent histamine H3 receptor antagonist, [3,4-3H2]-cyclohex-yl-¿[4-(3H-imidazol-4-yl)-piperidin-l-yl] iminomethyl¿- amine ([3H]GR168320), to homogenates of rat cerebral cortex. Specific binding of [3H]GR168320 at 37 degrees C associated and dissociated rapidly. Binding was saturable (Bmax 412 +/- 89 fmol/mg protein) and of high affinity (Kd 0.12 +/- 0.11 nM). Saturation studies suggested the involvement of a single site. Histamine H3 receptor agonists and antagonists inhibited [3H]GR168320 binding with high affinity. Agonist and antagonist affinities correlated when compared with affinities obtained using the tritiated histamine H3 agonist radioligand N alpha-methylhistamine.
我们检测了强效组胺H3受体拮抗剂的氚化衍生物[3,4-3H2]-环己基-¿[4-(3H-咪唑-4-基)-哌啶-1-基]亚氨基甲基¿-胺([3H]GR168320)与大鼠大脑皮层匀浆的特异性结合。在37℃时,[3H]GR168320的特异性结合快速缔合和解离。结合具有饱和性(Bmax为412±89 fmol/mg蛋白质)且亲和力高(Kd为0.12±0.11 nM)。饱和研究表明涉及单一结合位点。组胺H3受体激动剂和拮抗剂以高亲和力抑制[3H]GR168320的结合。与使用氚化组胺H3激动剂放射性配体Nα-甲基组胺获得的亲和力相比,激动剂和拮抗剂的亲和力具有相关性。